Table 1.
Mice group | Serum inflammatory mediators following treatments (pg/ml) | ||||||
---|---|---|---|---|---|---|---|
IFN-γ | TNF-α | IL-1β | IL-6 | IL-10 | IL12p70 | CRP | |
LFKO−/−C | 30.0±2.1 | 16.5±2. | 115.0±1.4 | 27.5±2.1 | 47.5±11 | 21.0±1.4 | 0.5±0.09 |
LFKO−/−C+hLF | 36.0±1.4 | 22.5±0.7 | 18.0±0.08 | 2.0±2.8* | 49.5±4.9 | 26.0±1.4 | 0.9±0.00 |
LFKO−/−I | 813.0±29.3# | 42.5±2.4# | 17.5±0.0# | 96.0±4.9# | 46.0±2.1# | 19.0±1.4# | 1.8±0.04# |
LFKO−/−I+hLF | 81.0±11.6¶§ | 24.5±4.7¶§ | 20.0±1.7¶§ | 216.0±4.9$§ | 59.0±7.1$§ | 23.5±3.8¶§ | 1.0±0.04¶§ |
Serum samples were collected at 48 h post-infection with or without hLF prophylaxis. The inflammatory cytokines were quantified after S. mutans and or hLF i.v. injections from serum samples. Significance in the levels was analyzed in triplicate experiments using Student’s t test and ANOVA and post hoc Tukey’ HST test between the groups.
p<0.05 between LFKO−/−C vs. LFKO−/−C+hLF groups,
p<0.05 significant difference between LFKO−/−C vs. LFKO−/−I groups,
p<0.05 significant difference between LFKO−/−I vs. LFKO−/−I+hLF groups,
p<0.05 significant difference between LFKO−/−C+hLF vs. LFKO−/−I+hLF groups,
p<0.05 significant difference between LFKO−/−C vs. LFKO−/−I+hLF groups.